NAUT

$2.29-2.55%visit website

Nautilus Biotechnology, Inc.

Market Cap

$292M

Live price × SEC shares (Oct 22, 2026)

Sector

Health Care

Industry

Life Sciences Tools & Services

Beta (raw)

0.64

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2026 · negative earnings

P/S (TTM)

—

Mkt cap / TTM revenue

P/B

2.5

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	Q3 FY2026 Sep 30, 2026	TTM Sep 30, 2026
Revenue			190	234
Cost of revenue			15.0	24.0
Research & development	9,575	9,707	9,613	10,176	39,071
Selling, general & administrative		6,417	6,325	6,771
Total operating expenses	15,424	16,124	15,938	16,947	64,433
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(13,781)	(14,697)	(14,469)	(15,636)	(58,583)
EPS (basic) ($)		(0.12)	(0.11)	(0.12)	(0.46)
EPS (diluted) ($)		(0.12)	(0.11)	(0.12)	(0.46)
Weighted avg. shares (basic)		126,635	127,136	127,238
Weighted avg. shares (diluted)		126,635	127,136	127,238

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Oct 27, 2026, period ended Sep 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 22 more quarters, back to Q2 FY2020, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 27, 2026 accepted 6:46 PM ET	2.02Earnings release	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

49%

W/W +21.8pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-02	2026-06-04	AH Equity Partners Bio II, L.L.C.	10% Owner	Sale	5.00M	$2.35	$11.75M	971.9K	View
2026-03-04	2026-03-04	Patel Sujal M	Director & CEO, President, and Secretary	Purchase	25.0K	$2.61	$65K	10.37M	View

Recent News

Nautilus Biotechnology: Bullish On Voyager's Upcoming Launch

SeekingAlpha · 2026-10-28

Nautilus Biotechnology, Inc. Q3 2026 Earnings Call Summary

Yahoo · 2026-10-27

Nautilus (NAUT) Q3 2026 Earnings Call Transcript

Yahoo · 2026-10-27

Nautilus Biotechnology Q3 Earnings Call Highlights

Yahoo · 2026-10-27

Nautilus Biotechnology, Inc. (NAUT) Q3 2026 Earnings Call Transcript

SeekingAlpha · 2026-10-27

Nautilus Biotechnology (NASDAQ:NAUT) Q3 Earnings Beat and Pipeline Progress Drive Premarket Surge

ChartMill · 2026-10-27

Nautilus to Measure Proteoforms Driving Alzheimer’s Disease and Cancer in ARPA-H-Funded SEEDS Consortium

Yahoo · 2026-10-27

Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

Yahoo · 2026-10-27

Nautilus Biotechnology Q3 2026 Earnings Call Transcript

Benzinga · 2026-10-27

Nautilus Biotechnology Announces Participation In SEEDS Research Consortium, Which Was Awarded Up To $51.7M By The Advanced Research Projects Agency For Health

Benzinga · 2026-10-27

12 Health Care Stocks Moving In Monday's Intraday Session

Benzinga · 2026-10-26

12 Health Care Stocks Moving In Friday's Intraday Session

Benzinga · 2026-10-23

NAUT Stock Climbs As Roth Sets Bullish $3.50 Target

Timothy Sykes · 2026-10-19

Nautilus Biotechnology to Announce Third Quarter 2026 Financial Results on October 27, 2026

Yahoo Finance · 2026-10-15

NAUT Stock Climbs As Wall Street Backs Voyager Platform

StocksToTrade · 2026-10-02

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-06-02	AH Equity Partners Bio II, L.L.C.	S	4,615,974	$11M
2026-06-02	AH Equity Partners Bio II, L.L.C.	S	384,026	$902,461.1
2026-03-04	Patel Sujal M	P	25,000	$65,237.5

NAUT

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Nautilus Biotechnology, Inc. (NAUT)

Reporting Insiders

Factor Profile

Corporate Events (8-K)